KRS Global Biotechnology, Inc. Announces New Compounded Oral Rinse

KRS Global Biotechnology (KRS-GBT), premier compounding pharmacy and FDA registered human drug compounding outsourcing facility under Section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), is excited to announce an addition to their already extensive lines: a compounded oral rinse that may assist with the management of oral mucositis symptoms.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

KRS Global Biotechnology

Boca Raton, FL (PRWEB) June 07, 2014

KRS Global Biotechnology introduced innovative-compounded oral rinses that may offer a safe and effective alternative for the management of side effects associated with chemotherapy treatments, such as oral mucositis. The symptoms of oral mucositis can include sores, inflammation, bleeding gums, and dry mouth.

A representative from the company stated, “Current oral rinses are not as affective in their adhering properties to allow for proper healing. We have considered this in compounding our oral rinse so that it would adhere to the oral lining providing comfort to the patient for a longer period. We also added special molecules that open up the pores in the mouth to allow for better penetration of medication to assist with healing and provide comfort to the patient. In addition, we compound topical creams and nasal spray that may assist with patients experiencing other side effects from their cancer treatments. These may include nausea, dermatitis, lymph edema, and sexual dysfunction.”

All of the formulations contain a combination of FDA approved ingredients. These include antifungal, anesthetics, anti-inflammatory, and antihistamines. Their team of scientists and pharmacists, who creatively developed the formulas, ensures proper safety and efficacy for the end user. Their team is dedicated to providing physicians’ patients with pharmaceutical solutions to enhance the overall patient benefit.

KRS-GBT has had very positive feedback from patients thus far. Ahava E., a recent user of the oral rinse says, “Thankfully, the sores that I have from the first treatment of chemotherapy were mild so far in comparison [to her first round of treatment], however after using the mouth gel only one time, I barely noticed them at all! The effect of the mouth gel was so powerful; I think I can confidently stop sucking on ice throughout the actual chemo treatment knowing that I can rely on the mouth gel. The rinse is a miracle treatment for mouth sores. I feel a lot calmer now about my next chemotherapy (supposed to be Tuesday) just knowing I don't have to fear those horrible sores.” Ahava posts on her blog at: http://ma-ma-bla-bla.blogspot.com/2014/03/blown-away.html?spref=fb&m=1

Their recent registration with the FDA as an out sourcing facility has propelled the company to the forefront of the compounding industry. They strive to be a leader and the example for others to follow with quality control and new innovative ideas for delivery systems for certain medications. They believe this registration will allow them to grow together with the needs of their customers and continue to provide the highest quality service and compounded pharmaceuticals.


Contact

Attachments